Stereotaxis to Participate in Piper Sandler 34th Annual Healthcare Conference
November 28 2022 - 9:07AM
Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical
robotics for minimally invasive endovascular intervention, today
announced that David Fischel, Chairman and CEO, will participate in
the Piper Sandler 34th Annual Healthcare Conference.
Mr. Fischel will present on Stereotaxis’
business and technology during a Fireside Discussion on Thursday,
December 1, 2022, at 9:00 am ET. He will then join a panel
discussion on “The Future of Robotic Surgery” the same day at 10:00
am ET. Mr. Fischel will be available for one-on-one meetings the
remainder of the day.
“We appreciate the invitation to participate in
this event and look forward to sharing Stereotaxis’ differentiated
technology, clinical value, and growth strategy with investors,”
says Mr. Fischel.
About StereotaxisStereotaxis
(NYSE: STXS) is a pioneer and global leader in innovative surgical
robotics for minimally invasive endovascular intervention. Its
mission is the discovery, development and delivery of robotic
systems, instruments, and information solutions for the
interventional laboratory. These innovations help physicians
provide unsurpassed patient care with robotic precision and safety,
expand access to minimally invasive therapy, and enhance the
productivity, connectivity, and intelligence in the operating room.
Stereotaxis technology has been used to treat over 100,000 patients
across the United States, Europe, Asia, and elsewhere. For more
information, please visit www.stereotaxis.com
Stereotaxis Contacts:David L.
FischelChairman and Chief Executive Officer
Kimberly PeeryChief Financial Officer
314-678-6100investors@stereotaxis.com
Stereotaxis (AMEX:STXS)
Historical Stock Chart
From Aug 2024 to Sep 2024
Stereotaxis (AMEX:STXS)
Historical Stock Chart
From Sep 2023 to Sep 2024